DT
Precision BioSciences, Inc.
DTIL · NASDAQ
$6.67 +0.15% (+$0.01)
1M -21.07%
Market Cap $85.6M
P/E Ratio -
Div. Yield -
ROE 91.60%
Bulios Fair Price
$9.68
45.1% upside
Trenutna cena
$6.67
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DTIL trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
84 /100
Cheap P/S 1.90x
P/B 1.89x
P/E N/A
Growth
77 /100
Growing Rev. growth 10.93%
Book val. growth 15.14%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 117.04%
Op. margin 80.78%
Quality
5 /100
Poor ROIC 30.23%
ROE 91.60%
ROA 41.88%
Debt
57 /100
Moderate Debt/Equity 0.62x
Current ratio 12.82x
Int. coverage -39.59x
Stability
15 /100
Unstable Beta 1.25x
Rev. volatility 72.96%
EPS volatility 307.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DTIL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Amoroso
Employees
67
Headquarters
Durham
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report